CN Stock MarketDetailed Quotes

Sino Medical Sciences Technology Inc. (688108)

Watchlist
  • 22.46
  • +0.57+2.60%
Trading Jan 8 09:32 CST
9.34BMarket Cap277.28P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sino Medical Sciences Technology Inc. (688108) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
Total operating revenue
14.24%363.85M
12.53%240.48M
10.75%100.85M
33.64%458.74M
30.20%318.49M
32.49%213.69M
24.46%91.06M
77.99%343.26M
47.42%244.62M
46.22%161.29M
Operating revenue
14.24%363.85M
12.53%240.48M
10.75%100.85M
33.64%458.74M
30.20%318.49M
32.49%213.69M
24.46%91.06M
77.99%343.26M
47.42%244.62M
46.22%161.29M
Total operating cost
-1.87%348.94M
-1.74%234.4M
-6.78%106.84M
17.58%490.84M
17.88%355.58M
17.01%238.54M
11.61%114.62M
4.71%417.46M
-0.57%301.66M
0.16%203.87M
Operating cost
1.22%124.79M
0.27%87.43M
-2.17%40.68M
23.80%174.59M
21.88%123.28M
27.92%87.19M
21.73%41.58M
98.26%141.03M
80.46%101.15M
83.44%68.16M
Operating tax surcharges
104.06%4.2M
87.59%2.87M
84.06%1.2M
61.44%3.65M
33.62%2.06M
71.27%1.53M
247.07%653.18K
192.56%2.26M
131.19%1.54M
111.05%892.12K
Operating expense
-0.82%54.59M
-4.07%35.5M
-8.91%15.1M
24.93%78.95M
17.93%55.04M
17.43%37.01M
16.15%16.58M
14.42%63.2M
18.73%46.67M
26.41%31.51M
Administration expense
5.62%69.38M
10.57%46.93M
18.87%22.32M
-5.37%89.49M
-6.86%65.69M
-15.49%42.44M
-31.37%18.78M
-20.88%94.57M
-26.46%70.53M
-17.63%50.22M
Financial expense
3.53%3.22M
-6.50%1.97M
-6.01%953.11K
55.85%3.6M
144.81%3.11M
216.13%2.11M
709.63%1.01M
396.50%2.31M
201.09%1.27M
157.21%667.4K
-Interest expense (Financial expense)
-7.96%3.86M
-10.57%2.52M
-5.97%1.33M
49.74%5.61M
63.65%4.2M
81.73%2.82M
130.01%1.41M
47.04%3.75M
27.29%2.57M
20.95%1.55M
-Interest Income (Financial expense)
-0.11%-1.68M
-13.20%-1.26M
-17.45%-714.75K
8.03%-2.42M
16.56%-1.68M
14.71%-1.11M
13.62%-608.54K
11.52%-2.63M
22.96%-2.01M
33.00%-1.31M
Research and development
-12.83%92.76M
-12.53%59.71M
-26.18%26.58M
23.19%140.56M
32.19%106.41M
30.23%68.26M
35.46%36.01M
-25.33%114.1M
-28.58%80.5M
-35.48%52.42M
Credit Impairment Loss
-38.96%69.5K
61.49%-39.53K
-261.91%-47.66K
-69.65%426.62K
-46.45%113.87K
84.99%-102.64K
107.70%29.43K
205.58%1.41M
118.52%212.64K
-121.02%-683.89K
Asset Impairment Loss
113.69%1.08M
204.29%3.36M
202.62%3.74M
-291.47%-18.05M
-36.26%-7.9M
-51.05%-3.22M
-370.82%-3.64M
68.21%-4.61M
-3.90%-5.8M
25.83%-2.13M
Other net revenue
Fair value change income
----
----
----
----
----
----
-65.52%38.73K
----
--30.21K
----
Invest income
----
----
----
339.54%11.19M
412.60%11.19M
584.18%11.19M
940.70%11.13M
-13.68%-4.67M
-18.58%-3.58M
-20.38%-2.31M
-Including: Investment income associates
----
----
----
----
----
----
----
-5.37%-4.95M
----
----
Asset deal income
----
----
----
120.44%287.34K
----
----
----
-30,809.34%-1.41M
--29.49
----
Other revenue
-4.77%15.77M
1.68%11.87M
-12.93%6.57M
51.26%21.28M
59.89%16.56M
60.98%11.68M
38.59%7.54M
113.23%14.07M
215.55%10.36M
154.51%7.25M
Operating profit
285.97%31.85M
500.91%21.27M
150.37%4.26M
75.56%-16.97M
69.32%-17.12M
86.89%-5.3M
65.24%-8.46M
68.33%-69.42M
61.22%-55.82M
57.62%-40.46M
Add:Non operating Income
245.66%2.26M
284.70%2.26M
-99.98%69.69
-66.02%617.92K
2,746.03%653.76K
2,491.33%586.51K
3,872,274,100.00%387.23K
1,699.28%1.82M
2,062.07%22.97K
4,161.70%22.63K
Less:Non operating expense
131.43%588.13K
2,814.54%511.35K
-20.39%13.7K
214.69%810.41K
11.08%254.13K
-91.08%17.54K
-83.72%17.21K
-88.62%257.53K
-81.38%228.77K
543.25%196.77K
Total profit
300.41%33.52M
585.93%23.01M
152.51%4.25M
74.71%-17.16M
70.15%-16.72M
88.35%-4.74M
66.90%-8.09M
69.34%-67.86M
61.41%-56.03M
57.46%-40.64M
Less:Income tax cost
813.81%12.8M
299.98%9.84M
134.78%1.53M
45.75%-13.27M
84.26%-1.79M
41.70%-4.92M
24.00%-4.4M
49.08%-24.46M
62.27%-11.39M
59.60%-8.44M
Net profit
238.77%20.72M
6,969.39%13.17M
173.69%2.72M
91.04%-3.89M
66.55%-14.93M
100.58%186.27K
80.24%-3.68M
74.96%-43.4M
61.18%-44.63M
56.85%-32.2M
Net profit from continuing operation
238.77%20.72M
6,969.39%13.17M
173.69%2.72M
90.41%-3.89M
66.55%-14.93M
100.58%186.27K
80.24%-3.68M
76.60%-40.56M
61.18%-44.63M
56.85%-32.2M
Net income from discontinuing operating
----
----
----
----
----
----
----
---2.84M
----
----
Less:Minority Profit
90.08%-398.26K
79.63%-673.18K
87.38%-253.95K
-42.91%-5.39M
-39.04%-4.02M
-27.84%-3.3M
17.35%-2.01M
65.51%-3.77M
52.18%-2.89M
23.66%-2.58M
Net profit of parent company owners
293.46%21.12M
296.54%13.84M
277.50%2.97M
103.78%1.5M
73.85%-10.92M
111.79%3.49M
89.68%-1.67M
75.59%-39.63M
61.68%-41.75M
58.43%-29.61M
Earning per share
Basic earning per share
266.67%0.05
200.00%0.03
350.00%0.01
104.00%0.004
70.00%-0.03
114.29%0.01
90.00%-0.004
75.00%-0.1
62.96%-0.1
58.82%-0.07
Diluted earning per share
266.67%0.05
200.00%0.03
350.00%0.01
104.00%0.004
70.00%-0.03
114.29%0.01
90.00%-0.004
75.00%-0.1
62.96%-0.1
58.82%-0.07
Other composite income
115.04%234.16K
166.31%761.91K
109.67%127.5K
-342.29%-1.09M
-278.87%-1.56M
-177.92%-1.15M
-165.43%-1.32M
-82.87%448.56K
-75.54%870.6K
-3.16%1.47M
Other composite income of parent company owners
115.04%234.16K
166.31%761.91K
109.67%127.5K
-342.29%-1.09M
-278.87%-1.56M
-177.92%-1.15M
-165.43%-1.32M
-82.87%448.56K
-75.54%870.6K
-3.16%1.47M
Total composite income
227.08%20.95M
1,546.90%13.93M
156.82%2.84M
88.41%-4.98M
62.32%-16.49M
96.87%-962.77K
73.86%-5M
74.84%-42.95M
60.72%-43.76M
57.97%-30.72M
Total composite income of parent company owners
271.19%21.35M
523.68%14.6M
203.51%3.1M
101.05%410.99K
69.49%-12.47M
108.32%2.34M
82.09%-2.99M
75.48%-39.18M
61.21%-40.88M
59.64%-28.14M
Total composite income of minority owners
90.08%-398.26K
79.63%-673.18K
87.38%-253.95K
-42.91%-5.39M
-39.04%-4.02M
-27.84%-3.3M
17.35%-2.01M
65.51%-3.77M
52.18%-2.89M
23.66%-2.58M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
--
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
--
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023
Total operating revenue 14.24%363.85M12.53%240.48M10.75%100.85M33.64%458.74M30.20%318.49M32.49%213.69M24.46%91.06M77.99%343.26M47.42%244.62M46.22%161.29M
Operating revenue 14.24%363.85M12.53%240.48M10.75%100.85M33.64%458.74M30.20%318.49M32.49%213.69M24.46%91.06M77.99%343.26M47.42%244.62M46.22%161.29M
Total operating cost -1.87%348.94M-1.74%234.4M-6.78%106.84M17.58%490.84M17.88%355.58M17.01%238.54M11.61%114.62M4.71%417.46M-0.57%301.66M0.16%203.87M
Operating cost 1.22%124.79M0.27%87.43M-2.17%40.68M23.80%174.59M21.88%123.28M27.92%87.19M21.73%41.58M98.26%141.03M80.46%101.15M83.44%68.16M
Operating tax surcharges 104.06%4.2M87.59%2.87M84.06%1.2M61.44%3.65M33.62%2.06M71.27%1.53M247.07%653.18K192.56%2.26M131.19%1.54M111.05%892.12K
Operating expense -0.82%54.59M-4.07%35.5M-8.91%15.1M24.93%78.95M17.93%55.04M17.43%37.01M16.15%16.58M14.42%63.2M18.73%46.67M26.41%31.51M
Administration expense 5.62%69.38M10.57%46.93M18.87%22.32M-5.37%89.49M-6.86%65.69M-15.49%42.44M-31.37%18.78M-20.88%94.57M-26.46%70.53M-17.63%50.22M
Financial expense 3.53%3.22M-6.50%1.97M-6.01%953.11K55.85%3.6M144.81%3.11M216.13%2.11M709.63%1.01M396.50%2.31M201.09%1.27M157.21%667.4K
-Interest expense (Financial expense) -7.96%3.86M-10.57%2.52M-5.97%1.33M49.74%5.61M63.65%4.2M81.73%2.82M130.01%1.41M47.04%3.75M27.29%2.57M20.95%1.55M
-Interest Income (Financial expense) -0.11%-1.68M-13.20%-1.26M-17.45%-714.75K8.03%-2.42M16.56%-1.68M14.71%-1.11M13.62%-608.54K11.52%-2.63M22.96%-2.01M33.00%-1.31M
Research and development -12.83%92.76M-12.53%59.71M-26.18%26.58M23.19%140.56M32.19%106.41M30.23%68.26M35.46%36.01M-25.33%114.1M-28.58%80.5M-35.48%52.42M
Credit Impairment Loss -38.96%69.5K61.49%-39.53K-261.91%-47.66K-69.65%426.62K-46.45%113.87K84.99%-102.64K107.70%29.43K205.58%1.41M118.52%212.64K-121.02%-683.89K
Asset Impairment Loss 113.69%1.08M204.29%3.36M202.62%3.74M-291.47%-18.05M-36.26%-7.9M-51.05%-3.22M-370.82%-3.64M68.21%-4.61M-3.90%-5.8M25.83%-2.13M
Other net revenue
Fair value change income -------------------------65.52%38.73K------30.21K----
Invest income ------------339.54%11.19M412.60%11.19M584.18%11.19M940.70%11.13M-13.68%-4.67M-18.58%-3.58M-20.38%-2.31M
-Including: Investment income associates -----------------------------5.37%-4.95M--------
Asset deal income ------------120.44%287.34K-------------30,809.34%-1.41M--29.49----
Other revenue -4.77%15.77M1.68%11.87M-12.93%6.57M51.26%21.28M59.89%16.56M60.98%11.68M38.59%7.54M113.23%14.07M215.55%10.36M154.51%7.25M
Operating profit 285.97%31.85M500.91%21.27M150.37%4.26M75.56%-16.97M69.32%-17.12M86.89%-5.3M65.24%-8.46M68.33%-69.42M61.22%-55.82M57.62%-40.46M
Add:Non operating Income 245.66%2.26M284.70%2.26M-99.98%69.69-66.02%617.92K2,746.03%653.76K2,491.33%586.51K3,872,274,100.00%387.23K1,699.28%1.82M2,062.07%22.97K4,161.70%22.63K
Less:Non operating expense 131.43%588.13K2,814.54%511.35K-20.39%13.7K214.69%810.41K11.08%254.13K-91.08%17.54K-83.72%17.21K-88.62%257.53K-81.38%228.77K543.25%196.77K
Total profit 300.41%33.52M585.93%23.01M152.51%4.25M74.71%-17.16M70.15%-16.72M88.35%-4.74M66.90%-8.09M69.34%-67.86M61.41%-56.03M57.46%-40.64M
Less:Income tax cost 813.81%12.8M299.98%9.84M134.78%1.53M45.75%-13.27M84.26%-1.79M41.70%-4.92M24.00%-4.4M49.08%-24.46M62.27%-11.39M59.60%-8.44M
Net profit 238.77%20.72M6,969.39%13.17M173.69%2.72M91.04%-3.89M66.55%-14.93M100.58%186.27K80.24%-3.68M74.96%-43.4M61.18%-44.63M56.85%-32.2M
Net profit from continuing operation 238.77%20.72M6,969.39%13.17M173.69%2.72M90.41%-3.89M66.55%-14.93M100.58%186.27K80.24%-3.68M76.60%-40.56M61.18%-44.63M56.85%-32.2M
Net income from discontinuing operating -------------------------------2.84M--------
Less:Minority Profit 90.08%-398.26K79.63%-673.18K87.38%-253.95K-42.91%-5.39M-39.04%-4.02M-27.84%-3.3M17.35%-2.01M65.51%-3.77M52.18%-2.89M23.66%-2.58M
Net profit of parent company owners 293.46%21.12M296.54%13.84M277.50%2.97M103.78%1.5M73.85%-10.92M111.79%3.49M89.68%-1.67M75.59%-39.63M61.68%-41.75M58.43%-29.61M
Earning per share
Basic earning per share 266.67%0.05200.00%0.03350.00%0.01104.00%0.00470.00%-0.03114.29%0.0190.00%-0.00475.00%-0.162.96%-0.158.82%-0.07
Diluted earning per share 266.67%0.05200.00%0.03350.00%0.01104.00%0.00470.00%-0.03114.29%0.0190.00%-0.00475.00%-0.162.96%-0.158.82%-0.07
Other composite income 115.04%234.16K166.31%761.91K109.67%127.5K-342.29%-1.09M-278.87%-1.56M-177.92%-1.15M-165.43%-1.32M-82.87%448.56K-75.54%870.6K-3.16%1.47M
Other composite income of parent company owners 115.04%234.16K166.31%761.91K109.67%127.5K-342.29%-1.09M-278.87%-1.56M-177.92%-1.15M-165.43%-1.32M-82.87%448.56K-75.54%870.6K-3.16%1.47M
Total composite income 227.08%20.95M1,546.90%13.93M156.82%2.84M88.41%-4.98M62.32%-16.49M96.87%-962.77K73.86%-5M74.84%-42.95M60.72%-43.76M57.97%-30.72M
Total composite income of parent company owners 271.19%21.35M523.68%14.6M203.51%3.1M101.05%410.99K69.49%-12.47M108.32%2.34M82.09%-2.99M75.48%-39.18M61.21%-40.88M59.64%-28.14M
Total composite income of minority owners 90.08%-398.26K79.63%-673.18K87.38%-253.95K-42.91%-5.39M-39.04%-4.02M-27.84%-3.3M17.35%-2.01M65.51%-3.77M52.18%-2.89M23.66%-2.58M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --------------Unqualified opinion----
Auditor --------------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +14.57%
Sample Name
Sample Code
 +10.25%
Sample Name
Sample Code
 +9.94%
4
JD HEALTH
06618
+9.38%
5
ALI HEALTH
00241
+8.61%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.49%
Sample Name
Sample Code
 +4.33%
Sample Name
Sample Code
 +2.43%
4
Block
XYZ
+2.10%
5
Comcast
CMCSA
+1.75%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -